blog- Pharmaffiliates



heart health for women
Published on July 25, 2019 by pharmaffiliates

Women’s Health: Heart Disease Symptoms and Control

It is estimated by the Centers for Disease Control and Prevention that one in four women in the world suffers from heart diseases. U.S. FDA helps women of all ages to learn how to use FDA-approved drugs and devices safely to prevent ...
Read More


We Expertise in Impurity Profiling at Pharmaffiliates
Published on July 18, 2019 by pharmaffiliates

We Expertise in Impurity Profiling at Pharmaffiliates

It is necessary to assure that the observed pharmacologic or toxicological effects of a drug substance or Drug product are truly due to the compound of interest and not due to impurities. Furthermore, it is also important to ensure that the product formulated for marketing does not generate any impurities during its shelf life that would cause deleterious effects....
Read More

Amlodipine-A Little More Than a Calcium Channel Blocker
Published July 15, 2019 by pharmaffiliates

Amlodipine-A Little More Than a Calcium Channel Blocker

Calcium Channel Blocker drugs are mainly known for the treatment of hypertension and angina. But, lesser it is known that Amlodipine which belongs to this category possess antioxidant activity and plays an important role in apoptosis...
Read More

Published on July 1, 2019 by Pharmaffiliates

FAME Analysis-Critical for Nutritional Labeling

Migraine – A most common brain disabling disorder is a condition characterized by the experience of migrainous headache on at least 15 days per month. Migraine has wide‐reaching implications for society, healthcare services, and the economy..
Read More